BIO Asia–Taiwan 2026
Partner with Thermo Fisher Scientific at BIO Asia–Taiwan 2026
Your trusted global CDMO for large and small molecules, clinical trial solutions,
and streamlined drug development.
July 15–19, 2026 | TaiNEX 1 & 2, Taipei, Taiwan
About the tradeshow:
Jointly organized by the Biotechnology Innovation Organization (BIO) and the Taiwan Bio Industry Organization (Taiwan BIO), BIO Asia–Taiwan 2026 is one of Asia’s premier biotechnology and life sciences events, bringing together global industry leaders, innovators, investors, and solution providers from across the biopharmaceutical ecosystem.
Under the theme “Asian Inspiration, Global Impact,” BIO Asia–Taiwan 2026 highlights the growing influence of Asia’s biotechnology sector and the power of innovation and AI to connect regional breakthroughs with global opportunities. The event serves as a platform for collaboration across drug development, manufacturing, supply, and regulatory affairs.
Event details
Date: July 15-19, 2026
Format: In-person
Location: TaiNEX 1 & 2 halls, Taipei, Taiwan
Booth number: M1031
Event website:
BIO Asia–Taiwan 2026
Why Thermo Fisher Scientific?
At Thermo Fisher Scientific, we deliver end-to-end CDMO solutions that support every stage of your drug development journey. From traditional small and large molecules to advanced modalities such as gene therapies and mRNA, our global network and scientific expertise help streamline your path from discovery to commercialization.
Our key offerings include:
- Development and manufacturing for large and small molecules, gene therapies, mRNA, and more
- Services and support for research studies, clinical trial packaging, labeling, and global distribution
- Accelerator™ Drug Development approach, streamlining the path from IND to commercial launch
Visit us at booth M1031 to learn how we can help bring life-changing medicines to patients faster and more efficiently.
Attend our expert-led session:
- Date: July 16, 2026, 14:00–14:50
- Venue: TaiNEX 5F, Meeting Room 506
Accelerating Drug Development: How Emerging Biotechs Can Navigate the Path to Global Clinical and Commercial Success
Speaker:
Koji Tanimoto
Senior Director, Business Development, Asia Pacific and Japan
Pharma Services, Thermo Fisher Scientific
Taiwan’s biotechnology sector continues to gain global momentum, with innovative companies advancing promising therapies across a broad range of modalities. Successfully navigating the journey from development to commercialization requires not only scientific innovation, but also the right expertise, capabilities, and strategic partnerships.
Come explore key trends and practical strategies for speeding up market access and global expansion. We will highlight how our integrated CDMO solutions support biopharma companies from early development through commercial manufacturing, enabling greater efficiency, reduced risk, and a faster path to delivering life-changing therapies.
Pre-book a meeting with us
Let’s connect at BIO Asia-Taiwan 2026 by pre-scheduling a 1:1 meeting. Click the button below to secure time with our experts while in Taipei.
Stay connected to new discoveries, innovations, and expert scientific opinions.
Follow us on social media for the latest up-to-date event happenings.
We look forward to seeing you soon